Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of ASEPCO^® Corporation (Asepco).

Watson-Marlow Fluid Technology Group (WMFTG), the world leader in niche peristaltic pumps and associated fluid path technologies, has acquired Asepco through its parent company Spirax-Sarco Engineering plc, for £7.0 million. Asepco, based in California USA, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.

Asepco is a natural extension of the Watson-Marlow Fluid Technology Group fluid path product portfolio and further strengthens WMFTG’s already strong global presence in the biotechnology and pharmaceutical industries.  Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.    

Jay Whalen, President of the Watson-Marlow Fluid Technology Group comments: "The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow's position in the biopharmaceutical market.  This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise”.

Steve Joy, Asepco President will remain in his role. Steve brings a wealth of experience to WMFTG. Prior to joining Asepco, Steve had previous experience of founding and growing a business with Jensen Fittings.

Steve commented, “I am very excited to be part of the Watson-Marlow Fluid Technology Group and look to drive sales further with the expansive WMFTG sales network.”

more about watson-marlow fluid technology

more news from watson-marlow fluid technology